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Abstract: Incubation of synaptosomes with [3 H]acetate results in rapid labeling of protein. Labeling is decreased in the presence of veratridine, and the
effect of veratridine is blocked by tetrodotoxin. Most of the radioactivity
can be removed by base or acid hydrolysis, and is probably incorporated
as acetate; it is this fraction that is affected by the veratridine. The data suggest that veratridine stimulates deacetylation of synaptosomal protein. This
raises the question whether acetylation-deacetylation is involved in membrane
function. Key Words: Acetylation-Synaptosomes-Proteins-VeratridineTetrodotoxin. Berl S. et al. Acetylation of synaptosomal protein: Inhibition
by veratridine. J. Neurochem. 40, 176- 183 (1983).
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Isolated nerve ending particles prepared from
brain (synaptosomes) take up, synthesize, and release putative neurotransmitters (Marchbanks,
1969; Blaustein et al., · 1972; De Belleroche and
Bradford, 1973; Levy et al., 1974). They contain
specific mechanisms for the transport of Ca2 +, N a+,
and K + across their membranes (Lust and Robinson, 1970; Blaustein et al., 1972; Swanson et al.,
1974; Blaustein, 1975) and ion flux studies show that
sodium channels in synaptosomes have the same
functional properties as those in intact nerve cells
(Mathews et al., 1979; Krueger and Blaustein,
1980). Synaptosomes ~lso retain a membrane potential (Blaustein and Goldring, 1975; Creveling et
al., 1980) and bind neurotoxins to receptor sites associated with sodium channels (Abita et al., 1977;
Catterall et al., 1979; 1981).
Actin, myosin, and tropomyosin have been identified in synaptosomal preparations (Puszkin et al.,
1972; Blitz and Fine, 1974). Furthermore, actin
(Wang and Mahler, 1976; Schwartz et al., 1977;
Blomberg et al., 1977; Cohen et al., 1977; Mahler,
1977; Kelly and Cotman, 1978), myosin (Beach and
Cotman, 1979), and the calcium regulator protein
calmodulin (Grab et al., 1979; Lin et al., 1980;
Wood et al., 1980) have been shown to be present in

synaptic membrane sites. The physiological activity
of the contractile proteins in synaptic membranes
has not yet been established. In part this is owing to
the difficulty of formulating studies in which
changes in this system could be related to function.
It has been suggested that the actomyosin system
present in nerve terminals functions in the release of
transmitter materials at synaptic junctions (Poisner,
1970; Berl et al., 1973). Little direct evidence in
support of such a function has been reported
(Babitch et al., 1979).
Several of the proteins associated with this
system--e.g., actin (Krans et al., 1965; Gaetjens
and Barany, 1966), myosin (Offer, 1964), tropomyosin (Stone and Smillie, 1978; Mak et al., 1980), .
troponin C (Collins et al., 1977), and calmodulin
(Watterson et al., 1980)-have a property in common; namely, their NH 2 -terminal amino acid is
blocked by the acetyl moiety covalently bound to
the amino group. The functional significance of this
terminal group is not known.
A number of years ago we observed that radiolabeled acetate can be incorporated into brain
proteins, from which it can be readily released by
acid hydrolysis and driven out upon drying in vacuum. This suggested to us that acetate may be
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with 5.5 mM glucose; TTX, Tetrodotoxin.
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rapidly turning over in proteins as the acetyl moiety
and might serve as a marker for synaptosomal activity. Therefore a study was undertaken to determine whether or not labile acetate incorporation can
be demonstrated in synaptosomes and whether such
incorporation would be affected by conditions that
cause stimulated release of neurotransmitters.
The data reported in this paper support the latter
notions. However, the results obtained to date provide no evidence for the participation of the contractile proteins in these processes.
MATERIALS AND METHODS
3

H]Acetate (2 Ci/mmol) was obtained from New England Nuclear; veratridine and sodium fluoroacetate from
Sigma Chemical Company; and tetrodotoxin (TTX) and
D,L-fluorocitrate (barium salt) from Calbiochem.
Before use, 0.10 volume of 0.1 M NaOH was added to
aliquots of the tritiated acetate, and the ethanol in which it
was supplied was evaporated at ooc with a gentle stream
of N 2 • The residue was dissolved in the same volume of
H 2 0. The veratridine was dissolved in 50% ethanol prior
to use. The TTX was dissolved in 1.6 mM citrate buffer,
pH 4. 7. Control studies with amounts of ethanol, citrate
buffer, or barium chloride equivalent to the amounts
present experimentally showed that these substances
were without effect on acetate incorporation.
The synaptosomes were prepared from the cerebral
hemispheres of Sprague-Dawley rats by the flotation procedure of Booth and Clark (1978). Critical examination of
this preparation has shown its purity to be approximately
85% or more (Deutsch et al., 1981).
[

c

Labeling of synaptosomes

•

•

The synaptosomal pellet was suspended in KrebsRinger phosphate fortified with 5.5 mM glucose (KRP)
and oxygenated with 95% 02 -5% C0 2 prior to use (2.5- 3
mg of synaptosomal protein/ml). The incubation temperature was 37°C, and the synaptosomes were kept at this
temperature for 5- 10 min before any additions were
made. The final concentration of added [3H]acetate was
approximately 0.05 mM (100 ~-tCi/ml) (unless otherwise
stated); of veratridine 10- 100 ~-tM; and of TTX 2 ~-tM,
obtained by adding 0.01 ml of each stock solution per ml
of synaptosomal suspension. Batrachotoxin (1 ~-tM) was
also added in some preliminary experiments.
Following incubation for varying periods of time (lOs - 15
min), 1-ml samples were immediately mixed with 0.1
ml of 4 M perchloric acid and kept in ice until centrifugation. The precipitates were exhaustively washed six
times with 5 ml of 0.4 M perchloric acid and twice with
organic sol vents. The first three perchloric acid washes
also contained 10 mM sodium acetate. In early experiments the protein was repeatedly washed with organic
solvents by the procedure of Siekevitz (1952). In most of
the experiments the protein was washed with acidified
chloroform-methanol (3 :2) and in later experiments also
with ether. With either method, the last wash contained
no radioactivity, nor were the results affected by either
procedure. The protein was dissolved in 1 ml of 1 M
NaOH at 60°C.
To determine how much of the radioactivity was incorporated in a hydrolyzable and acid-volatile state , proba-
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bly as acetate, and how much was incorporated into the
protein, probably as amino acids, portions of the protein
(0.4 ml) were heated at 100°C in 1 M NaOH for 1-2 h.
they were then acidified with 1 ml of 2M HCl and dried in
vacuum at 60-65°C; the residue was dissolved in 1 ml2 M
HCl and again dried. Four milliliters of water was added,
and the protein was dried again. The residue was dissolved in 1.2 ml of water and 1 ml was counted. A greater
percentage of volatile radioactivity was obtained by acid
hydrolysis with 2M HCl for 3 h at 100°C (approximately
75-80% versus approximately 65%). This procedure was
used in later experiments. Volatile radioactivity was calculated as the difference between total radioactivity and
that remaining after hydrolysis.
Controls were run by adding the tritiated acetate to the
synaptosomal preparation after the addition of the perchloric acid. Following the washing procedure the remaining radioactivity was approximately 10% or less of
that usually found after 1 min of incubation. Following
hydrolysis all of the radioactivity was acid-volatile.
Protein concentration was determined by the procedure
of Lowry et al. (1951), with bovine serum albumin as a
standard. Radioactivity was counted by liquid scintillation spectrometry in a Packard Tricarb instrument. Internal standards of 3H 20 were used for the conversion of
cpm to dpm.

RESULTS

Effect of veratridine and tetrodotoxin on
labeling of protein
Veratridine, TTX, or both were added to the
synaptosomal suspension 1-2 min prior to addition
of the [3H]acetate, and samples were taken at the
indicated time periods (Fig. 1). The labeling of the
protein was rapid and nonlinear beyond approximately 1.5 min. At 1 min after the addition of the
3
[ H]acetate the veratridine-treated synaptosomal
protein contained approximately 17% less radioactivity than did the control protein, and this difference increased gradually with time largely because
of continued labeling of the control samples.
Further labeling of the protein was inhibited by veratridine (Fig. 1); TTX alone had no effect. The presence of TTX completely blocked the effect of veratridine, and therefore these values, as well as those
with TTX alone, were averaged with the controls.
As seen in Fig. 1, the major effect of veratridine
occurred in the first 1- 2 min.
Upon base hydrolysis and acid drying approximately two-thirds of the radioactivity was lost and
one-third was not acid-volatile (Fig. 2). This latter
fraction was apparently not affected by the presence of veratridine; it was the hydrolyzable and
acid-volatile radioactivity that was inhibited by the
veratridine from incorporation into the protein, as
shown by the decreased amount found therein.
In order to define the initial slope of the incorporation curve, 1-ml samples were incubated in separate tubes, the reaction being stopped by the addition of 0.1 ml of 4 M perchloric acid added at 10, 20,
30, and 60 s. As seen in Fig. 3, the initial rate of
J . N eurochem., Vol. 40, No . 1, 1983
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FIG. 2. Effect of veratridine on the distribution of labile
radioactivity in the synaptosomal protein . Experimental conditions are the same as in Fig. 1. Aliquots of the protein were
base-hydrolyzed, acidified, and dried as described in the text.
(-)Nonvolatile radioactivity;(---) volatile radioactivity; (e) no
drug ; (0 ) TTX; ( x ) veratridine; (.6) TTX + veratridine.
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FIG. 1. Effect of veratrid ine on the labeling of synaptosomal
protein with [3 H]acetate. Suspensions of synaptosomes in ·
KRP were preincubated for 10 min at 3rC. At 1-min intervals
TTX, veratridine, and [3 H]acetate (1 00 ~-tCi/ml, 0.05 ~-tmol)
were added and 1-ml samples taken at the indicated times
after addition of the [3 H]acetate. (e) Averaged values obtained with no drug, with TTX (2 ~-tM), and with TTX + veratridine (75- 100 ~-tM); (x ) veratridine, 75 - 100 ~-tM; (0 ) difference between the averaged and the veratridine values. The
bars represent SEM; the numbers in parentheses represent
the number of experimental values averaged.

acetate incorporation was greater than was estimated in Fig. 1. The effect of veratridine was evident even at 10 s after the addition of [3H]acetate.

Effect of veratridine on prelabeled proteins
The synaptosomal suspension in separate aliquots was prelabeled by incubation for 20 min in
the presence of [3 H]acetate. At 1-min intervals,
TTX, veratridine, or both were then added to the
separate flasks and 1-ml samples taken at 1, 5, 10,
and 15 min. The synaptosomal protein was labeled
by the [3 H]acetate, but further labeling was again
completely inhibited by the addition of veratridine,
that in the control samples continuing to rise at a
low rate (Fig. 4A). At 1 min the veratridine-treated
synaptosomal protein contained approximately 15%
less radioactivity than the control without veratridine. The decreased percentage of label in the
J. N eurochem. , Vol. 40, N o. 1, 1983

veratridine-treated samples was due to an absolute
loss of radioactivity, as well as an increased labeling
of the control sample. It appeared that in the pressence of veratridine a portion of the radioactive
acetate previously attached to protein was removed. The presence of TTX blocked the effect of
the veratridine, and the labeling of the protein was
even greater than that in the control samples (Fig.
4A). In Fig. 4B, the loss of radioactivity after base
hydolysis and drying under acidic conditions is depicted. The same general effects of veratridine and
TTX were observed under these conditions as previously. The loss of radioactivity due to incubation
with veratridine was in the volatile fraction, following hydrolysis. It should be noted that the same
difference curves between control and veratridinetreated samples were obtained before and after
hydrolysis (compare Fig. 4A and 4B). Extrapolation back to zero time (point of addition of veratridine) suggests that the effect of veratridine was
extremely rapid , with no time lag.
In another set of experiments the release of label
from the protein caused by the presence of veratridine was examined by the addition of the veratridine to the synaptosomal suspension in the same
flask after previous labeling with [3H]acetate (Fig.
5). Samples were taken at 1, 2, and 5 min. Veratridine (1 00 p.,M) was added, and samples were taken
at 6, 7, and 10 min. Addition of the veratridine
caused a rapid loss in the amount of acidhydrolyzable, volatile radioactivity from the protein; it had no effect on the nonvolatile fraction.
Similar results were obtained with batrachotoxin ( 1
p.,M), another neurotoxin whose action is similar to
that of veratridine, but is much more potent (data
not shown).

Acetate chase
Another demonstration of the labile nature of a
part of the incorporated acetate is shown in Fig. 6.
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FIG. 3. Initial rate of labeling of synaptosomal protein with
3
[ H]acetate and the effect of veratridine. One-milliliter
aliquots of the synaptosomal suspension were preincubated
for 10 min. Veratridine (1 00 J.LM) was added to one set of
tubes and after 1 min [3 H]acetate was added (1 00 J.LCi, 0.05
J.Lmol) to both sets. The reaction was stopped after 1O, 20, 30,
and 60s by the addition of 0.1 ml of 4 M perchloric acid. The
results from two experiments are shown. (e) Without veratridine; (0) with veratridine.

After labeling the synaptosomal suspension for 5
min, unlabeled sodium acetate (10 mM) was added
and samples taken at 15 s, 1 min, and 5 min. A rapid
exchange and dilution of the acid-hydrolyzable and
volatile radioactivity was observed. Again there
was no effect on the nonvolatile portion of the
radioactivity.

Effect of temperature
Aliquots of the synaptosomal suspension were
incubated at 0 or 37°C. After 10 min of preincubation veratridine was added, and 1 min later the
labeled acetate was added and samples were taken
at 1, 2, and 5 min. At 1 min after addition of the
labeled acetate the incorporation of the radioactivity into the protein was approximately 50% less at 0
than at 37°C (Table 1). The percent inhibition decre.ased with time, apparently because the incorporation of the labeled acetate approached its peak at
approximately 1 min at 37°C, whereas at ooc the
incorporation of radiolabeled acetate continued
over the entire experimental time period and had
not yet peaked at 5 min. At ooc the effect of veratridine was not evident at 1 min, although the char-

FIG. 4. Prelabeling of synaptosomal protein with [3 H]acetate
and the effect of veratridine. Suspensions of synaptosomes
in KRP were preincubated for 5 min at 3rC, [3 H]Acetate (1 00
J.LCi/ml, 0.05 J.LmOI) was added and incubation continued for
20 min . Then at 1-min intervals TTX and veratridine were
added and 1-ml samples were taken at indicated times after
addition of the veratridine. (A) Total radioactivity in the protein; (B) radioactivity removed from the protein by base hydrolysis and drying under acidic conditions. (e) No drug; (x )
veratridine; (0) average of TTX and TTX + veratridine; (0 ) no
drug - veratridine. The bars represent SEM.

acteristic inhibition of labeled acetate incorporation
was evident at 37oc (Table 1).

Effect of inhibitors
The effect of the metabolic inhibitors fluoroacetate and fluorocitrate on the incorporation of
labeled acetate into the synaptosomal protein was
measured (Table 2). The additional effect of veratridine was also determined. Fluoroacetate at 10 mM
inhibited the incorporation of the tritiated acetate
by 31-34%. Fluorocitrate at 1 mM inhibited the
incorporation of the tritiated acetate by 34- 43%.
The presence of veratridine was not additive but
consistently increased the inhibition caused by the
fluoroacetate and fluorocitrate to a small extent.
The inhibitory effects were somewhat higher in the
base-hydrolyzed, acid-volatile fraction than in the
total incorporated radioactivity. Fluoroacetate at 1
mM concentration had a slight effect in inhibiting
the incorporation of the labeled acetate (data not
shown).
Effect of acetate concentration
Rates of incorporation were measured at 30 s with
increasing amounts of tritiated acetate (Table 3).
The incorporation of total radioactivity, as well as
the acid-hydrolyzable volatile radioactivity, was
approximately proportional to the amount of ace-

J. N eurochem. , Vol. 40, No . 1, 1983
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FIG. 5. The effect of the addition of veratridine to a synaptosomal suspension labeled with [3 H]acetate. The synaptosomal suspension was preincubated for 10 min. [3 H]Acetate was added (1 00 ~-tCi, 0.05 ~-tmol/ml) and 1-ml samples
were taken at 1, 2, and 5 min. Veratridine was added (1 00 ~-tM)
and 1-ml samples taken at 6, 7, and 10 min. The 1-ml samples
were immediately mixed with 0.1 ml 4 M perchloric acid.
Aliquots of the proteins were counted, acid-hydrolyzed, and
dried as described in Materials and Methods. The results are
averages of two experiments. (e) Total radioactivity; (0) acid
hydrolyzed - volatile radioactivity; _., nonvolatile radioactivity. Arrows indicate time of addition of veratridine.

completely inhibited by TTX. It is clear that TTX
acts externally on membranes and has only a single
known pharmacological action, that is, the specific
blocking of sodium channels (Ritchie and Rogart,
197_7; Catterall, 1980).
The data presented here suggest that incorporation of acetate into protein, probably as the acetyl
group, is affected by veratridine. It is not proved,
(although it might logically be expected) that this
incorporation is in the NH 2 -terminal amino acid,
since a number of proteins are known in which the
TABLE 1. Effe ct of temperature on the incorporation of
[3 H]acetate into synaptosomal protein
Minutes
1

tate added. The veratridine effect was evident at the
three concentrations of acetate used.
Effect of Ca 2 + and K+
The presence or absence of calcium (2 mM Ca2 +
or 1 mM EGT A) did not have a significant effect on
the action of veratridine. High concentrations of K +
( 100 rnM) also had no effect on the labeling of the
synaptosomal protein by acetate (data not shown).
Therefore the inhibition of incorporation of acetate
does not appear to be related to depolarization of
the membrane.
DISCUSSION

It is well established that veratridine has a major
effect on sodium channels, causing them to open
and thereby stimulating the entrance of N a+ and
Ca2 + and the release of transmitter materials from
presynaptic sites (Ulbricht, 1969; Blaustein et al.,
1972; De Belleroche and Bradford, 1973; Narahashi, 1974; Abita et al., 1977). These effects are

J. Neurochem. , Vol. 40, No . 1, 1983

2

5

36
0
25

20
14
31

Total radioactivity

ooca

Veratridine at oocb
Veratridine at 37°C a

50
0
22

Acid-hydrolyzed, volatile radioactivity

ooca

Veratridine at oocb
Veratridine at 37°C a

49
0
28

35
7

10
14
36

Acid-hydrolyzed, nonvolatile radioactivity

ooca
V eratridine at ooc b
Veratridine at 37oa

48
0
0

38
0

36
15
14

Synaptosomes were incubated at 0 or 37°C . After 10 min of
preincubation, veratridine (1 00 ~-tM, final concentration) was
added. One minute later [3 H]acetate (100 ~-tCi, 0.047 ~-tmol
acetate/ml) was added and samples taken at 1, 2, and 5 min and
mixed with 0.1 ml of 4 M perchloric acid. See Materials and
Methods for further details. Values are percentage of inhibition
and are averages of two experiments.
a Compared with controls run at 37°C.
b Compared with the ooc values.

•

ACETYLATION OF SYNAPTOSOMAL PROTEIN
TABLE 2. Effect of inhibitors on the incorporation of
fH]acetate into synaptosomal protein
Minutes
Inhibitor

1

2

5

29.1
33.7
45.8
33.0
45.3

31.0
33.6
48.7
43.4
46.1

Total radioactivity
Veratridine
Fl uoroacetate
Fluoroacetate + veratridine
Fluorocitrate
Fluorocitrate + veratridine

25.0
31.3
42.5
33.5
40.6

Based-hydrolyzed, acid-volatile radioactivity

"

Veratridine
Fluoroacetate
Fluoroacetate + veratridine
Fluorocitrate
Fluorocitrate + veratridine

30.2
36.0
49.6
42.2
45.3

37.0
42.5
50.5
39.6
51.0

31.0
43.0
51.2
45.0
49.1

Synaptosomes in Krebs-Ringer phosphate were preincubated
for 5 min at 37°C. Fluoroacetate (10 m.M) or fluorocitrate (1
m.M) was added and incubation continued for 15 min prior to
addition of veratridine ( 100 J-tM), followed in 2 min by [3 H]acetate (100 ~-tCi, 0.047 ~-tmol!ml). One-milliliter samples were
taken at 1, 2, and 5 min and mixed with 0.1 ml 4 M perchloric
acid. See Materials and Methods for further details .
Values are percentage inhibition and are averages of three
experiments.

NH2 -terminal amino acid is blocked by the acetyl
moiety. However, the acetate may also be bound in
an acetyl-0-linkage or in glycoproteins. We are now
attempting to identify the proteins into which the
acetate is incorporated.
It has been demonstrated that actin acetylation
probably occurs as a posttranslational process and
that under certain conditions a small amount of
nonacetylated actin may exist in brain preparations
(Palmer and Saborio, 1978; Rubenstein and DeuchTABLE 3. Incorporation of [3 H) acetate into
synaptosomal protein with increasing concentration
offH]acetate
[

f

3

Total dpm/mg protein
H]Acetate
(m.M)

- Veratridine

+ Veratradine

0.036
0.072
0.144

10,800
18,860
36,730

9035
17,610
33,370

Acid-hydrolyzable and volatile, dpm/mg protein
0.036
0.072
0.144

7760
14,770
27,380

6400
13 ,385
24,770

One-milliliter aliquots of synaptosomal suspension were preincubated for 10 min at 37°C. [3H]Acetate (2.4 Cilmmol) was
added and the reaction stopped after 30 s by the addition of
0.1 ml 4 M perchloric acid. Veratridine (100 ~-tM) was added
to one set of tubes 2 min prior to the addition of the [3 H]acetate. Other details are given in Materials and Methods.
Values are those of a representative experiment.
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ler, 1979; Garrels and Hunter, 1979; Palmer et al.,
1980). In the present study, hydrolyzable, acidvolatile radioactivity was found associated with
crude synaptosomal actin; however, the radioactivity did not concentrate as the actin was carried
through several steps of purification. These findings
suggest that actin is probably not the major protein
into which the acetate is incorporated.
The identification of the protein or proteins into
which the acetate is incorporated is rendered difficult by the small amount of [3 H]acetate fixed in the
protein. We estimate on the basis of the added acetate that 1-2 pmol/mg protein is bound. If the
synaptosomes contain acetate in concentrations
usually found in tissue (Knowles et al., 1974; Tyee
et al., 1981), then the amount fixed could be 3-6
pmol/mg protein. This amount is of the same order
of magnitude as that found for the binding of TTX to
synaptosomal membranes (Abita et al., 1977) and
of TTX or saxitoxin to other conducting membranes
(Ritchie and Rogart, 1977). The binding of these
toxins is related to the density of the N a+ channels
in the membranes.
The inhibition of incorporation of acetate at ooc
and in the presence of the inhibitors fluoroacetate
and fluorocitrate indicates that the incorporation is
probably enzymatic. The toxicity offluoroacetate is
usually attributed to its conversion to fluorocitrate,
and to the reversible inhibition of aconitase in the
Krebs citric acid cycle (Peters, 1972). However,
Goldberg et al. (1966) have shown that fluoroacetate
at a dose of 100 mg/kg in mice did not lower ATP
levels or affect high-energy phosphate stores in
brain even though it produced convulsions at 20 and
40 min. Gonda and Quastel (1966) showed that
fluoroacetate (1 mM) did not inhibit 0 2 utilization,
14
C0 2 production from glucose, or ATP formation
by rat brain cortex slices. Paradoxically, it did inhibit metabolism of acetate and its conversion to
amino acids (Gonda and Quastel, 1966; Clarke et
al., 1970). Since fluoroacetate can be converted to
fluoroacetyl CoA, it is possible that its toxicity may
be due in part to fluoroacetylation of synaptosomal
protein. In addition, Kun et al. (1977) have shown
that fluorocitrate is bound to protein associated
with the citrate transport system in mitochondrial
membranes. Further work is required to determine
more specifically whether or not these inhibitors
affect membrane function, e.g., uptake or release of
transmitter substances or ionic flux, by binding to
membrane proteins.
The chase experiments with unlabeled acetate
support the idea that the acetylation process is rapid
and reversible. The results of the experiments in
which the veratridine was added to the acetylated
protein agree with the interpretation that in the
presence of veratridine deacetylation of a portion of
the protein occurs. The data suggest that the veratridine stimulates deacetylation rather than inhibits
J. Neurochem., Vol. 40, No. 1, 1983
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acetylation of protein and thus establishes a new
steady state in the ratio of acetylation to deacetylation. It is conceivable that deacetylation and acetylation of proteins can sufficiently change their conformation or polarity to permit movement of protein
from less polar to more polar regions of the membrane and vice versa, and thus affect opening and
closing of ionic channels and/ or transmitter release.
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